Plasma Plasminogen Activator Inhibitor Activity in Rats with Nutritionally Induced Insulin Resistance

• References

• 1 Vague P, Juhan-Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250-253
• 2 Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor I levels: A possible link between insulin resistance and atherothrombosis. Diabetologia 1991; 34: 457-462
• 3 Armstrong ML, Heistad DD. Animal models of atherosclerosis. Atherosclerosis 1990; 85: 15-23
• 4 Quax PH A, Van Den Hoogen M, Verheijen JH, Padro T, Zeheb R, Gelehrter TD. et al Endotoxin induction of plasminogen activator and PAI 1 mRNA in rat tissues in vivo. J Biol Chem 1990; 265: 5560-5569
• 5 Dosne AM, Dubor F, Chedid L. Plasminogen activator inhibitor induced by lipopolysaccharide injection in the rat. Zymographic analysis Fibrinolysis 1987; 1: 45-49
• 6 Schneiderman J, Sawdey M, Loskutoff DJ. Chronic dexamethasone treatment modulates the response of the PAI 1 gene to LPS in rats. Thromb Haemost 1991; 65: 652
• 7 Sawdey MS, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. J Clin Invest 1991; 88: 1346-1353
• 8 Rizkalla ZN, Mandenoff A, Betoulle D, Boillot J, Apfelbaum M. Decreased insulin binding to adipocytes precedes both hyperinsulinemia and decreased insulin binding to erythrocytes in cafeteria fed rats. Int J Obes 1987; 11: 493-505
• 9 Zavaroni I, Sander S, Scott S, Reaven GM. Effect of fructose feeding on insulin secretion and insulin action in the rat. Metabolism 1980; 29: 970-973
• 10 Lijnen HR, Webb PD, Van Hoef B, De Cock F, Stassen JH, Prior SD, Collen D. Biochemical and biological properties of a recombinant tissue- type plasminogen activator derived from the rat JMI-229 cell line. Thromb Haemost 1992; 67: 239-247